Pharmacologic Therapy

• IV hydralazine is now not primary parenteral therapy

• Labetolol has shown fewer side effects

  • Less

    • maternal hypotension
    • fewer C-sections
    • fewer placental abruptions
    • fewer low Apgar scores
  • Sl. more fetal bradycardia

Previous slide

Next slide

Back to first slide

View graphic version